Share Nominees Limited (Parkwalk) investment portfolio

Phasecraft builds quantum‑algorithm software and a materials‑discovery database that help commercial organisations solve optimisation and chemistry problems on quantum hardware. Their services target enterprises seeking practical quantum advantage for real‑world materials and optimisation challenges.

DefiniGEN supplies human induced pluripotent stem cell (iPSC)‑derived cell models and AI‑driven phenomics platforms for drug discovery, safety assessment and disease‑model research, serving pharmaceutical and biotech companies. Its services automate cell production, high‑content imaging and data analysis to generate predictive insights that accelerate therapeutic development.